APL has contributed to a new study in The Lancet Public Health that found public-private partnerships to develop, produce and distribute COVID-19 diagnostic tests saved approximately 1.4 million lives and prevented an estimated 7 million patient hospitalizations in the U.S. during the pandemic.

Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in humans - including those causing flu, COVID, whooping cough and tuberculosis.

About The Study: This cohort study found an association between COVID-19 and accelerated decline in kidney function, particularly after hospitalization, compared with pneumonia. People who were hospitalized for COVID-19 should receive closer monitoring of kidney function to ensure early diagnosis and optimized management of chronic kidney disease to effectively prevent complications and further decline.

For people with multiple sclerosis (MS), having a COVID-19 infection is not associated with worsening MS symptoms or disability, according to a study published in the December 23, 2024, online issue of Neurology^®, the medical journal of the American Academy of Neurology.

Growth mindset might help protect mental health during challenging times, being associated with lower levels of depression and higher well-being in COVID-19 pandemic study of Californian adults aged 19-89. 

This issue of Psychological Science in the Public Interest explores the cultural differences between the United States and East Asian countries that contributed to COVID-19 outcomes. 

About The Study: In this randomized clinical trial that compared a brief outpatient rehabilitation program with a cognitive and behavioral approach with usual care in 314 patients with post–COVID-19 condition, self-reported physical function improved statistically and clinically significantly in the intervention group after 2 to 8 outpatient encounters. The effect was sustained over time and adverse effects were negligible. This trial adds to the evidence supporting such interventions in routine clinical care. Future research should investigate which elements of this approach are the most effective and identify subgroups for which the current treatment is most relevant.

Stock investments by politicians have long drawn public scrutiny. Under a 2012 law, members of the U.S. Congress must disclose transactions over a $1,000 threshold. Early in the COVID-19 pandemic, lawmakers on both sides of the aisle were criticized for trading in everything from remote work technologies to telemedicine.

But less attention has been paid to what companies might gain from having politicians as shareholders. New research from Texas McCombs finds one indirect benefit: It might insulate companies from activist investors such as Carl Icahn or Nelson Peltz, who press for changes in their operations to drive up stock prices.

A new study uncovers how the COVID-19 pandemic reshaped emergency care for acute coronary syndrome, with a sharp decline in hospital visits nationwide. Analyzing over 61,000 cases, the research reveals that older adults, particularly women, were disproportionately affected, avoiding critical care during periods of high virus transmission. These findings shine a light on the unseen toll of public health crises, underscoring the urgent need to build trust and ensure access to life-saving care for vulnerable populations in future emergencies.

Half a decade on from the start of the COVID-19 pandemic, a study by the University of Surrey highlights the significant impact of combined public health measures in reducing airborne viral transmission. High-quality face masks were shown to reduce transmission risk by ninefold, while doubling indoor air ventilation cut the risk by nearly a third, providing valuable insights to support future prevention strategies for respiratory diseases. 

Research from Radboud university medical center shows that the lockdowns during the COVID-19 pandemic had a significant impact on people's immune response to microorganisms. During the lockdown, inflammation level in the body was low, but afterwards, the immune system reacted more intensely to viruses and bacteria. The results are now published in Frontiers of Immunology.

At the beginning of the COVID-19 pandemic, numerous studies had shown that COVID-19 patients with high levels of neutrophils, a key immune cell, presented with more severe disease and poor clinical outcomes. It was not clearly understood though how or why this was happening. A recently published study from Trinity researchers now sheds light on the role of neutrophils in COVID-19 and its contribution to the disease's progression. Their findings uncover potential mechanisms that could guide more effective treatments for severe COVID-19.  The study has been published in the journal JCI Insight.